Trefoil Therapeutics Funding: $50M Raised, Series B

Trefoil Therapeutics funding overview

Trefoil Therapeutics is based in San Diego, California. Trefoil Therapeutics has raised $50M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B. Investors on record include Bios Partners, Access Biotechnology, Aju IB Investment, Correlation Ventures, ExSight Ventures, Hatteras Venture Partners and 1 others. 7 distinct backers are named across the disclosed rounds.

Trefoil Therapeutics at a glance

Total raised: $50M
Latest round: Series B
Headquarters: San Diego, California
Notable investors: Bios Partners, Access Biotechnology, Aju IB Investment, Correlation Ventures, ExSight Ventures, Hatteras Venture Partners, InFocus Capital Partners

Frequently asked about Trefoil Therapeutics funding

How much has Trefoil Therapeutics raised?: Trefoil Therapeutics has raised $50M in total disclosed funding across the rounds on record.
Who has invested in Trefoil Therapeutics?: Bios Partners, Access Biotechnology, Aju IB Investment, Correlation Ventures, ExSight Ventures, Hatteras Venture Partners are named among the investors backing Trefoil Therapeutics.
What was the latest Trefoil Therapeutics funding round?: The most recent disclosed round is a Series B.
Where is Trefoil Therapeutics based?: Trefoil Therapeutics is based in San Diego, California.

Trefoil Therapeutics totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in San Diego below to benchmark round size and investor mix.

Trefoil Therapeutics Funding: $50M Raised, Series B

Trefoil Therapeutics funding overview

Trefoil Therapeutics at a glance

Frequently asked about Trefoil Therapeutics funding

Companies related to Trefoil Therapeutics (20)

Browse related funding lists (8)